BACKGROUND: Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infarction (STEMI) when primary percutaneous coronary intervention (PCI) cannot be done within 90 min. However, the best subsequent management of patients after thrombolytic therapy remains unclear. To assess the best management, we randomised patients with STEMI treated by thrombolysis and abciximab at a non-interventional hospital to immediate transfer for PCI, or to standard medical therapy with transfer for rescue angioplasty. METHODS: 600 patients aged 75 years or younger with one or more high-risk features (extensive ST-segment elevation, new-onset left bundle branch block, previous myocardial infarction, Killip class >2, or left ven...
Ambiguous data about comparability regarding clinical outcomes for prehospital thrombolysis, coupled...
Among physicians who treat patients with acute myocardial infarction, there is controversy about the...
BACKGROUND. The European Cooperative Study Group conducted two randomized trials in patients with su...
BACKGROUND: Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infa...
BACKGROUND: Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infar...
Background Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infarctio...
ObjectivesWe compared a strategy of tenecteplase (TNK)-facilitated angioplasty with one of TNK alone...
ObjectivesThe goal of this study was to compare a strategy of immediate transfer for percutaneous co...
Background Although thrombolytic therapy with rescue percutaneous coronary intervention (PCI) is a c...
Aims: As of to date, the only large transportation trial comparing on-site fibrin-specific thromboly...
BACKGROUND: As compared with thrombolytic therapy, primary percutaneous transluminal coronary angiop...
AbstractOBJECTIVESWe examined the utility of early percutaneous coronary intervention (PCI) in a tri...
Aims: As of to date, the only large transportation trial comparing on-site fibrin-specific thromboly...
Background We hypothesized that percutaneous coronary intervention (PCI) preceded by early treatment...
AbstractOBJECTIVESThe study evaluated the efficacy and safety of a short-acting reduced-dose fibrino...
Ambiguous data about comparability regarding clinical outcomes for prehospital thrombolysis, coupled...
Among physicians who treat patients with acute myocardial infarction, there is controversy about the...
BACKGROUND. The European Cooperative Study Group conducted two randomized trials in patients with su...
BACKGROUND: Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infa...
BACKGROUND: Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infar...
Background Thrombolysis remains the treatment of choice in ST-segment elevation myocardial infarctio...
ObjectivesWe compared a strategy of tenecteplase (TNK)-facilitated angioplasty with one of TNK alone...
ObjectivesThe goal of this study was to compare a strategy of immediate transfer for percutaneous co...
Background Although thrombolytic therapy with rescue percutaneous coronary intervention (PCI) is a c...
Aims: As of to date, the only large transportation trial comparing on-site fibrin-specific thromboly...
BACKGROUND: As compared with thrombolytic therapy, primary percutaneous transluminal coronary angiop...
AbstractOBJECTIVESWe examined the utility of early percutaneous coronary intervention (PCI) in a tri...
Aims: As of to date, the only large transportation trial comparing on-site fibrin-specific thromboly...
Background We hypothesized that percutaneous coronary intervention (PCI) preceded by early treatment...
AbstractOBJECTIVESThe study evaluated the efficacy and safety of a short-acting reduced-dose fibrino...
Ambiguous data about comparability regarding clinical outcomes for prehospital thrombolysis, coupled...
Among physicians who treat patients with acute myocardial infarction, there is controversy about the...
BACKGROUND. The European Cooperative Study Group conducted two randomized trials in patients with su...